tiprankstipranks
Trending News
More News >
Blueprint Medicines (BPMC)
NASDAQ:BPMC
US Market

Blueprint Medicines (BPMC) Technical Analysis

Compare
605 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Blueprint Medicines’s (BPMC) Moving Averages Convergence Divergence (MACD) indicator is 8.87, suggesting Blueprint Medicines is a Sell.
Blueprint Medicines’s (BPMC) 20-Day exponential moving average is 111.85, while Blueprint Medicines’s (BPMC) share price is $127.97, making it a Buy.
Blueprint Medicines’s (BPMC) 50-Day exponential moving average is 102.24, while Blueprint Medicines’s (BPMC) share price is $127.97, making it a Buy.

Blueprint Medicines (BPMC) Pivot Points

Jun 11, 2025, 07:19 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
127.42
127.60
127.72
127.90
128.02
128.20
128.32
Fibonacci
127.60
127.71
127.78
127.90
128.01
128.08
128.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Blueprint Medicines (BPMC) Moving Averages

Jun 11, 2025, 07:19 AM
Period
Simple
Exponential
MA5
127.88Buy
125.52Buy
MA10
116.70Buy
119.61Buy
MA20
108.65Buy
111.85Buy
MA50
96.45Buy
102.24Buy
MA100
97.55Buy
98.45Buy
MA200
94.47Buy
97.40Buy
Blueprint Medicines’s (BPMC) 10-Day exponential moving average is 119.61, while Blueprint Medicines’s (BPMC) share price is $127.97, making it a Buy.
Blueprint Medicines’s (BPMC) 100-Day exponential moving average is 98.45, while Blueprint Medicines’s (BPMC) share price is $127.97, making it a Buy.
Blueprint Medicines’s (BPMC) stock price is $127.97 and Blueprint Medicines’s (BPMC) 50-day simple moving average is 96.45, creating a Buy signal.
Blueprint Medicines’s (BPMC) stock price is $127.97 and Blueprint Medicines’s (BPMC) 100-day simple moving average is 97.55, creating a Buy signal.
Blueprint Medicines’s (BPMC) stock price is $127.97 and Blueprint Medicines’s (BPMC) 200-day simple moving average is 94.47, creating a Buy signal.

Blueprint Medicines (BPMC) Technical Indicators

Jun 11, 2025, 07:19 AM
Name
Value
Implied Action
RSI (14)
76.16
Sell
STOCH (9,6)
99.03
Sell
STOCHRSI (14)
99.03
Sell
MACD (12,26)
8.87
Sell
ADX (14)
31.91
Neutral
Williams %R
-0.78
Sell
CCI (14)
111.14
Sell
ATR (14)
4.04
-
Ultimate Oscillator
83.40
Buy
ROC
26.43
Buy
Blueprint Medicines’s (BPMC) Relative Strength Index (RSI) is 76.16, creating a Sell signal.
Blueprint Medicines’s (BPMC) Trend Strength Indicator (ADX) is 31.91, creating a Neutral signal.
Blueprint Medicines’s (BPMC) Commodity Channel Index (CCI) is 111.14, creating a Sell signal.
Blueprint Medicines’s (BPMC) Price Rate of Change (ROC) is 26.43, creating a Buy signal.

FAQ

Is BPMC a Buy, Hold, or Sell?
Based on BPMC’s technical indicators, BPMC is a Buy.
    What is BPMC’s RSI (14)?
    BPMC’s RSI (14) is 76.16, which suggests BPMC is a Sell.
      What is BPMC’s MACD?
      BPMC’s MACD is 8.87, which suggests BPMC is a Sell.
        What is BPMC’s 5-day moving average?
        BPMC’s 5-day moving average is 127.88, which suggests BPMC is a Buy.
          What is BPMC’s 20-day moving average?
          BPMC 20-day moving average is 108.65, which suggests BPMC is a Buy.
            What is BPMC’s 50-day moving average?
            BPMC’s 50-day moving average is 96.45, which suggests BPMC is a Buy.
              What is BPMC’s 200-day moving average?
              BPMC’s 200-day moving average is 94.47, which suggests BPMC is a Buy.
                What is BPMC’s Williams % R (14)?
                BPMC’s Williams % R (14) is -0.78, which suggests BPMC is a Sell.
                  What is BPMC’s CCI (14)?
                  BPMC’s CCI (14) is 111.14, which suggests BPMC is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis